Perceptive Discovery and Certis Oncology Announce Strategic Collaboration to Advance Radiopharmaceutical Development

BOSTON, June 1, 2026 /PRNewswire/ -- Perceptive Discovery, a leading preclinical CRO supporting radiopharmaceutical and oncology drug development, and Certis Oncology, an AI-enabled precision oncology and translational science company, today announced a strategic collaboration that...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.